Back to Search Start Over

Community-Reviewed Biological Network Models for Toxicology and Drug Discovery Applications.

Authors :
Alex Namasivayam, Aishwarya
Morales, Alejandro Ferreiro
Lacave, Angela Maria Fajardo
Tallam, Aravind
Simovic, Borislav
Alfaro, David Garrido
Bobbili, Dheeraj Reddy
Martin, Florian
Androsova, Ganna
Shvydchenko, Irina
Park, Jennifer
Calvo, Jorge Val
Hoeng, Julia
Peitsch, Manuel C.
Racero, Manuel Gonzalez Velez
Biryukov, Maria
Talikka, Marja
Perez, Modesto Berraquero
Rohatgi, Neha
Diaz-Diaz, Noberto
Mandarapu, Rajesh
Ruiz, Ruben Amian
Davidyan, Sergey
Narayanasamy, Shaman
Boue, Stephanie
Guryanova, Svetlana
Arbas, Susana Martinez
Menon, Swapna
Xiang, Yang
Alex Namasivayam, Aishwarya
Morales, Alejandro Ferreiro
Lacave, Angela Maria Fajardo
Tallam, Aravind
Simovic, Borislav
Alfaro, David Garrido
Bobbili, Dheeraj Reddy
Martin, Florian
Androsova, Ganna
Shvydchenko, Irina
Park, Jennifer
Calvo, Jorge Val
Hoeng, Julia
Peitsch, Manuel C.
Racero, Manuel Gonzalez Velez
Biryukov, Maria
Talikka, Marja
Perez, Modesto Berraquero
Rohatgi, Neha
Diaz-Diaz, Noberto
Mandarapu, Rajesh
Ruiz, Ruben Amian
Davidyan, Sergey
Narayanasamy, Shaman
Boue, Stephanie
Guryanova, Svetlana
Arbas, Susana Martinez
Menon, Swapna
Xiang, Yang
Publication Year :
2016

Abstract

Biological network models offer a framework for understanding disease by describing the relationships between the mechanisms involved in the regulation of biological processes. Crowdsourcing can efficiently gather feedback from a wide audience with varying expertise. In the Network Verification Challenge, scientists verified and enhanced a set of 46 biological networks relevant to lung and chronic obstructive pulmonary disease. The networks were built using Biological Expression Language and contain detailed information for each node and edge, including supporting evidence from the literature. Network scoring of public transcriptomics data inferred perturbation of a subset of mechanisms and networks that matched the measured outcomes. These results, based on a computable network approach, can be used to identify novel mechanisms activated in disease, quantitatively compare different treatments and time points, and allow for assessment of data with low signal. These networks are periodically verified by the crowd to maintain an up-to-date suite of networks for toxicology and drug discovery applications.

Details

Database :
OAIster
Notes :
English
Publication Type :
Electronic Resource
Accession number :
edsoai.on1388614291
Document Type :
Electronic Resource